United States · FDA National Drug Code directory
Cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-3725_3cc63f9c-2bd7-41d6-a5cd-ceb9be0d6d7b
- Product NDC
- 50090-3725
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cefdinir
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070508
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFDINIR MONOHYDRATE — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 mL in 1 BOTTLE (50090-3725-0) · 50090-3725-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →